Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

Yuanlong Ge; Shu Wu; Zepeng Zhang; Xiaocui Li; Feng Li; Siyu Yan; Haiying Liu; Junjiu Huang; Yong Zhao

doi:10.1007/s13238-019-0640-1

PDF(519 KB)

Protein Cell ›› 2019, Vol. 10 ›› Issue (12) : 927-928. DOI: 10.1007/s13238-019-0640-1

CORRECTION

Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

Yuanlong Ge¹^,² ,
Shu Wu¹^,² ,
Zepeng Zhang¹^,² ,
Xiaocui Li¹^,² ,
Feng Li¹ ,
Siyu Yan¹ ,
Haiying Liu¹^,² ,
Junjiu Huang¹ ,
Yong Zhao¹^,²

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Yuanlong Ge, Shu Wu, Zepeng Zhang, Xiaocui Li, Feng Li, Siyu Yan, Haiying Liu, Junjiu Huang, Yong Zhao. Correction to: Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers. Protein Cell, 2019, 10(12): 927‒928 https://doi.org/10.1007/s13238-019-0640-1